Quality of life (QOL) predicts for progression-free survival (PFS) in patients with metastatic renal cell carcinoma (mRCC) treated with sunitinib compared to interferon-alpha (IFN-α) Meeting Abstract
| Authors: | Cella, D.; Li, J. Z.; Cappelleri, J. C.; Bushmakin, A.; Charbonneau, C.; Kim, S. T.; Chen, I.; Michaelson, M. D.; Motzer, R. J. |
| Abstract Title: | Quality of life (QOL) predicts for progression-free survival (PFS) in patients with metastatic renal cell carcinoma (mRCC) treated with sunitinib compared to interferon-alpha (IFN-α) |
| Meeting Title: | 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 25 |
| Issue: | 18 Suppl. |
| Meeting Dates: | 2007 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2007-06-20 |
| Start Page: | 345s |
| Language: | English |
| ACCESSION: | WOS:000455043701562 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2007.25.18_suppl.6594 |
| Notes: | Meeting Abstract: 6594 -- Source: Wos |
